Microbiome-derived carnitine mimics as previously unknown mediators of gut-brain axis communication

Heather Hulme,Lynsey M Meikle,Nicole Strittmatter,Justin J J van der Hooft,John Swales,Ryan A Bragg,Victor H Villar,Michael J Ormsby,Stephanie Barnes,Sheila L Brown,Alex Dexter,Maya T Kamat,Jasper C Komen,Daniel Walker,Simon Milling,Emily K Osterweil,Andrew S MacDonald,Chris J Schofield,Saverio Tardito,Josephine Bunch,Gillian Douce,Julia M Edgar,RuAngelie Edrada-Ebel,Richard J A Goodwin,Richard Burchmore,Daniel M Wall

DOI: https://doi.org/10.1126/sciadv.aax6328

2020-03-11

Abstract:Alterations to the gut microbiome are associated with various neurological diseases, yet evidence of causality and identity of microbiome-derived compounds that mediate gut-brain axis interaction remain elusive. Here, we identify two previously unknown bacterial metabolites 3-methyl-4-(trimethylammonio)butanoate and 4-(trimethylammonio)pentanoate, structural analogs of carnitine that are present in both gut and brain of specific pathogen-free mice but absent in germ-free mice. We demonstrate that these compounds are produced by anaerobic commensal bacteria from the family Lachnospiraceae (Clostridiales) family, colocalize with carnitine in brain white matter, and inhibit carnitine-mediated fatty acid oxidation in a murine cell culture model of central nervous system white matter. This is the first description of direct molecular inter-kingdom exchange between gut prokaryotes and mammalian brain cells, leading to inhibition of brain cell function.